Investigative Ophthalmology & Visual Science Cover Image for Volume 57, Issue 12
September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Qualitative and quantitative follow-up of patients with retinal vein occlusion using Optical Coherence Tomography Angiography
Author Affiliations & Notes
  • Alexandre Sellam
    Regulatory Science, Creteil University , Paris, France
  • Florence Coscas
    Regulatory Science, Creteil University , Paris, France
  • Agnes Glacet-Bernard
    Regulatory Science, Creteil University , Paris, France
  • Alexandra Miere
    Regulatory Science, Creteil University , Paris, France
  • Gabriel J Coscas
    Regulatory Science, Creteil University , Paris, France
  • Eric H Souied
    Regulatory Science, Creteil University , Paris, France
  • Footnotes
    Commercial Relationships   Alexandre Sellam, None; Florence Coscas, None; Agnes Glacet-Bernard, None; Alexandra Miere, None; Gabriel Coscas, None; Eric Souied, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5474. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alexandre Sellam, Florence Coscas, Agnes Glacet-Bernard, Alexandra Miere, Gabriel J Coscas, Eric H Souied; Qualitative and quantitative follow-up of patients with retinal vein occlusion using Optical Coherence Tomography Angiography. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5474.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate qualitatively and quantitatively the results using Optical Coherence Tomography Angiography (OCTA) in the follow-up of patients treated with intravitreal injections for a macular edema secondary to retinal vein occlusion (RVO).

Methods : Retrospective study of RVO patients treated with intravitreal injections for a macular edema. Before and after injection, following data were recorded: best-corrected visual acuity (BCVA), Spectral Domain-Optical Coherence Tomography (SD-OCT), fluorescein angiography and OCT A (Optovue, Inc., Fremont, California, USA). Automatic measurement of vascular density of the superficial (SCP) and deep capillary plexus (DCP) was also done before and after treatment and compared to healthy subjects, matched for age and gender.

Results : 35 eyes of 34 patients (mean age, 68 years, male 64%) were retrospectively analyzed, including 16 central RVO, 15 branch RVO and 4 hemicentral RVO. After treatment, central macular thickness significantly decreased from 623µ to 326µ in average and BCVA increased from 20/100 to 20/63 (p<0.01 for both). On OCTA, a significant decrease of perifoveal capillary disruption was observed after treatment (p=0.02) as well as a decrease of vascular dilation in the SCP and the DCP (p=0.001 and 0.016 respectively) and of the number of cysts in the SCP and DCP (p<0.001 for both). At the SCP, the mean whole en face vascular density slightly decreased during follow-up from 45.7 to 44.5%, and the density in the parafoveal zone decreased from 47.2 to 45.8% (non-significant difference for both). These densities were largely inferior to those observed in control subjects (50.8% and 52.6% respectively, p<0.001 for both).

Conclusions : Along with the disappearance of macular edema and of macular cysts, OCTA visualized a slight decrease in macular vascular density with time and despite treatment. This technique allows a quantitative and qualitative evaluation of the follow-up of RVO patients, useful to analyze both macular edema and vascular perfusion.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×